Skip to main content

Katz Barrett's Form 4 filing

Viridian Therapeutics, Inc. (VRDN) · filed Jan 18, 2023

Accession no.
0000899243-23-002075
Filed
Jan 18, 2023
Trade date
Jan 13-17, 2023
Filing delay
5 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.08M. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Katz BarrettCIK 0001841628Officer (Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 13, 2023Common StockMOption exerciseAcquired+4,147$23.03+$95,505.414,147Direct
Jan 13, 2023Common StockSSaleDisposed−4,147$37.01−$153,480.470Direct
Jan 17, 2023Common StockMOption exerciseAcquired+24,853$23.03+$572,364.5924,853Direct
Jan 17, 2023Common StockSSaleDisposed−24,853$37.21−$924,780.130Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 13, 2023Common StockMOption exerciseDisposed−4,147$0.00$0291,853Direct
Jan 17, 2023Common StockMOption exerciseDisposed−24,853$0.00$0267,000Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)